Cargando…
Properdin: A Novel Target for Neuroprotection in Neonatal Hypoxic-Ischemic Brain Injury
Background: Hypoxic-ischemic (HI) encephalopathy is a major cause of neonatal mortality and morbidity, with a global incidence of 3 per 1,000 live births. Intrauterine or perinatal complications, including maternal infection, constitute a major risk for the development of neonatal HI brain damage. D...
Autores principales: | Sisa, Claudia, Agha-Shah, Qudsiyah, Sanghera, Balpreet, Carno, Ariela, Stover, Cordula, Hristova, Mariya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6902041/ https://www.ncbi.nlm.nih.gov/pubmed/31849925 http://dx.doi.org/10.3389/fimmu.2019.02610 |
Ejemplares similares
-
Properdin Levels in Human Sepsis
por: Stover, Cordula M., et al.
Publicado: (2015) -
Prognostic Value of Complement Properdin in Cancer
por: Mangogna, Alessandro, et al.
Publicado: (2021) -
Current Therapies for Neonatal Hypoxic–Ischaemic and Infection-Sensitised Hypoxic–Ischaemic Brain Damage
por: Tetorou, Konstantina, et al.
Publicado: (2021) -
Curcumin: Novel Treatment in Neonatal Hypoxic-Ischemic Brain Injury
por: Rocha-Ferreira, Eridan, et al.
Publicado: (2019) -
Properdin and Factor H: Opposing Players on the Alternative Complement Pathway “See-Saw”
por: Kouser, Lubna, et al.
Publicado: (2013)